Literature DB >> 19809332

Pathological and physiological hypertrophies are regulated by distinct gene programs.

Vidar Beisvag1, Ole Johan Kemi, Ingerid Arbo, Jan Pål Loennechen, Ulrik Wisløff, Mette Langaas, Arne Kristian Sandvik, Øyvind Ellingsen.   

Abstract

BACKGROUND: This study aims to investigate changes that occur during progression and establishment of physiological and pathological cardiac hypertrophy, by microarray technology and functional annotations. DESIGN AND METHODS: Myocardial infarction leading to heart failure was induced in rats, with animals killed 1, 3, 7, 14, 42, and 92 days after coronary artery ligation. A second group was subjected to daily treadmill exercise and killed 1, 4, 24, and 48 h after a single exercise bout, or after 28 or 56 days of exercise training.
RESULTS: Physiological hypertrophy was associated with less transcriptional alternation than pathological hypertrophy, indicating that posttranscriptional and translational regulation may be more important. The main difference between the two types of hypertrophy was that myocardial infarction was associated with downregulation of genes related to fatty acid metabolism, whereas no such change occurred after exercise training. Thus, fatty acid metabolism may distinguish adverse maladaptive hypertrophy from beneficial adaptive hypertrophy.
CONCLUSION: This study points to specific genes and gene classes related to biological processes that may be important in these well-characterized rat models of physiological and pathological cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19809332     DOI: 10.1097/HJR.0b013e32833158a2

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  12 in total

Review 1.  Cardiac adaptation to exercise training in health and disease.

Authors:  Dae Yun Seo; Hyo-Bum Kwak; Amy Hyein Kim; Se Hwan Park; Jun Won Heo; Hyoung Kyu Kim; Jeong Rim Ko; Sam Jun Lee; Hyun Seok Bang; Jun Woo Sim; Min Kim; Jin Han
Journal:  Pflugers Arch       Date:  2019-04-23       Impact factor: 3.657

Review 2.  Molecular Mechanisms Underlying Cardiac Adaptation to Exercise.

Authors:  Rick B Vega; John P Konhilas; Daniel P Kelly; Leslie A Leinwand
Journal:  Cell Metab       Date:  2017-05-02       Impact factor: 27.287

3.  Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo.

Authors:  S-L Puhl; A Kazakov; A Müller; P Fries; D R Wagner; M Böhm; C Maack; Y Devaux
Journal:  Br J Pharmacol       Date:  2015-11-16       Impact factor: 8.739

4.  Molecular pathways underlying cardiac remodeling during pathophysiological stimulation.

Authors:  Izhak Kehat; Jeffery D Molkentin
Journal:  Circulation       Date:  2010-12-21       Impact factor: 29.690

5.  Deep RNA sequencing reveals novel cardiac transcriptomic signatures for physiological and pathological hypertrophy.

Authors:  Hong Ki Song; Seong-Eui Hong; Taeyong Kim; Do Han Kim
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

6.  Will global transcriptome analysis allow the detection of novel prognostic markers in coronary artery disease and heart failure?

Authors:  Monika Gora; Marek Kiliszek; Beata Burzynska
Journal:  Curr Genomics       Date:  2013-09       Impact factor: 2.236

7.  The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure.

Authors:  Weihua Song; Xiaomeng Wang
Journal:  Biophys Rev       Date:  2015-01-15

8.  Cardioprotective effects of dietary lipids evident in the time-dependent alterations of cardiac function and gene expression following myocardial infarction.

Authors:  Jessica M Berthiaume; Salaman M Azam; Brian D Hoit; Margaret P Chandler
Journal:  Physiol Rep       Date:  2014-05-20

Review 9.  The role of mechanotransduction in heart failure pathobiology-a concise review.

Authors:  Wolfgang Krueger; Nicole Bender; Martin Haeusler; Maciej Henneberg
Journal:  Heart Fail Rev       Date:  2021-07       Impact factor: 4.214

10.  Herbal Supplement Ameliorates Cardiac Hypertrophy in Rats with CCl(4)-Induced Liver Cirrhosis.

Authors:  Ping-Chun Li; Yung-Wei Chiu; Yueh-Min Lin; Cecilia Hsuan Day; Guang-Yuh Hwang; Peiying Pai; Fuu-Jen Tsai; Chang-Hai Tsai; Yu-Chun Kuo; Hsiao-Chuan Chang; Jer-Yuh Liu; Chih-Yang Huang
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-06       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.